Methicillin-resistant Staphylococcus aureus (MRSA) is one of the most successful modern
pathogens. The same organism that lives as a commensal and is transmitted in both health …

Staphylococcus aureus is a major human pathogen that causes a wide range of clinical
infections. It is a leading cause of bacteremia and infective endocarditis as well as …

Daptomycin is a cyclic lipopeptide antibiotic used for the treatment of Gram-positive
infections including complicated skin and skin structure infections, right-sided infective …

Background We aimed to determine whether daptomycin plus fosfomycin provides higher
treatment success than daptomycin alone for methicillin-resistant Staphylococcus aureus …

A positive follow-up blood culture for methicillin-resistant Staphylococcus aureus (MRSA)
while on seemingly appropriate therapy is a common and ominous development. However …

Methicillin-resistant Staphylococcus aureus (MRSA) is a devastating pathogen responsible
for a variety of life-threatening infections. A distinctive characteristic of this pathogen is its …

Staphylococcus aureus bacteremia (SAB) carries a high risk for excess morbidity and
mortality. Despite its prevalence, significant practice variation continues to permeate clinical …

The emergence of glycopeptide reduced susceptibility and resistance in Staphylococcus
aureus strains is a growing clinical problem that poses significant clinical challenges in …

There has been a welcome increase in the number of agents available for the treatment of
methicillin-resistant Staphylococcus aureus (MRSA). Vancomycin remains an acceptable …

Introduction: Staphylococcus aureus remains one of the leading causes of morbidity and
mortality worldwide. This is to a large extent due to antibiotic-resistant strains, in particular …